FDA OPDP Offers Insight into Enforcement Strategy and Warning Letters Thomas Sullivan Feb 4, 2014 0 As part of CBI's Pharmaceutical Compliance Congress, Tom Abrams, director of the Food and Drug Administration's (FDA) Office of…
